PL358328A1 - Cyklipostyny, sposób ich wytwarzania i ich zastosowanie - Google Patents
Cyklipostyny, sposób ich wytwarzania i ich zastosowanieInfo
- Publication number
- PL358328A1 PL358328A1 PL01358328A PL35832801A PL358328A1 PL 358328 A1 PL358328 A1 PL 358328A1 PL 01358328 A PL01358328 A PL 01358328A PL 35832801 A PL35832801 A PL 35832801A PL 358328 A1 PL358328 A1 PL 358328A1
- Authority
- PL
- Poland
- Prior art keywords
- cyclipostins
- physiologically compatible
- production
- compounds
- same
- Prior art date
Links
- 229930183107 cyclipostin Natural products 0.000 title abstract 3
- 238000004519 manufacturing process Methods 0.000 title abstract 2
- 150000003839 salts Chemical class 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 2
- 239000000126 substance Substances 0.000 abstract 2
- 102000004882 Lipase Human genes 0.000 abstract 1
- 108090001060 Lipase Proteins 0.000 abstract 1
- 239000004367 Lipase Substances 0.000 abstract 1
- 241000187747 Streptomyces Species 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 235000019421 lipase Nutrition 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6564—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
- C07F9/6571—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms
- C07F9/6574—Esters of oxyacids of phosphorus
- C07F9/65744—Esters of oxyacids of phosphorus condensed with carbocyclic or heterocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6564—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
- C07F9/6571—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms
- C07F9/6574—Esters of oxyacids of phosphorus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P9/00—Preparation of organic compounds containing a metal or atom other than H, N, C, O, S or halogen
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/465—Streptomyces
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Genetics & Genomics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Obesity (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10021731A DE10021731B4 (de) | 2000-05-04 | 2000-05-04 | Cyclipostine, Verfahren zu ihrer Herstellung und pharmazeutische Zubereitung derselben |
PCT/EP2001/004652 WO2001083497A1 (de) | 2000-05-04 | 2001-04-25 | Cyclipostine, verfahren zu ihrer herstellung und verwendung derselben |
Publications (1)
Publication Number | Publication Date |
---|---|
PL358328A1 true PL358328A1 (pl) | 2004-08-09 |
Family
ID=7640768
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL01358328A PL358328A1 (pl) | 2000-05-04 | 2001-04-25 | Cyklipostyny, sposób ich wytwarzania i ich zastosowanie |
Country Status (28)
Country | Link |
---|---|
EP (1) | EP1280812B1 (pl) |
JP (1) | JP5038572B2 (pl) |
KR (1) | KR100779867B1 (pl) |
CN (1) | CN1216890C (pl) |
AR (1) | AR028398A1 (pl) |
AT (1) | ATE288442T1 (pl) |
AU (2) | AU6222901A (pl) |
BR (1) | BR0110459A (pl) |
CA (1) | CA2407808C (pl) |
CZ (1) | CZ20023547A3 (pl) |
DE (2) | DE10021731B4 (pl) |
DK (1) | DK1280812T3 (pl) |
EE (1) | EE05090B1 (pl) |
ES (1) | ES2236234T3 (pl) |
HK (1) | HK1055745A1 (pl) |
HR (1) | HRP20020864A2 (pl) |
HU (1) | HUP0300306A3 (pl) |
IL (2) | IL152612A0 (pl) |
MX (1) | MXPA02010297A (pl) |
NO (1) | NO330438B1 (pl) |
NZ (1) | NZ522352A (pl) |
PL (1) | PL358328A1 (pl) |
PT (1) | PT1280812E (pl) |
RU (1) | RU2266911C2 (pl) |
SK (1) | SK15602002A3 (pl) |
WO (1) | WO2001083497A1 (pl) |
YU (1) | YU81502A (pl) |
ZA (1) | ZA200208928B (pl) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8110665B2 (en) | 2003-11-13 | 2012-02-07 | Hanmi Holdings Co., Ltd. | Pharmaceutical composition comprising an immunoglobulin FC region as a carrier |
CN103212084B (zh) | 2003-11-13 | 2018-07-13 | 韩美科学株式会社 | 含有免疫球蛋白fc区作为载体的药物组合物 |
KR100754667B1 (ko) | 2005-04-08 | 2007-09-03 | 한미약품 주식회사 | 비펩타이드성 중합체로 개질된 면역글로불린 Fc 단편 및이를 포함하는 약제학적 조성물 |
EP1894601A1 (en) | 2006-08-29 | 2008-03-05 | sanofi-aventis | Treating mycobacterial infections with cyclipostins |
KR200453850Y1 (ko) * | 2008-04-23 | 2011-05-30 | 주식회사 에이티티알앤디 | 수질 관리 센서 내장형 수도미터기 |
KR102073748B1 (ko) | 2013-01-31 | 2020-02-05 | 한미약품 주식회사 | 재조합 효모 형질전환체 및 이를 이용하여 면역글로불린 단편을 생산하는 방법 |
AR096891A1 (es) | 2013-07-12 | 2016-02-03 | Hanmi Pharm Ind Co Ltd | Conjugado de monómero polipéptido biológicamente activo y conjugado de fragmento fc de inmunoglobulina, que muestra aclaramiento mediado por receptor reducido, y el método para la preparación del mismo |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH04145089A (ja) * | 1990-10-05 | 1992-05-19 | Nippon Kayaku Co Ltd | 抗生物質nk901093、その製造法及びそれを有効成分として含有する殺虫・殺ダニ剤 |
JPH0656859A (ja) * | 1991-07-25 | 1994-03-01 | Nippon Kayaku Co Ltd | 抗生物質nk901093a、その製造法及びそれを有効成分として含有する殺虫・殺ダニ剤 |
-
2000
- 2000-05-04 DE DE10021731A patent/DE10021731B4/de not_active Expired - Fee Related
-
2001
- 2001-04-25 MX MXPA02010297A patent/MXPA02010297A/es active IP Right Grant
- 2001-04-25 YU YU81502A patent/YU81502A/sh unknown
- 2001-04-25 SK SK1560-2002A patent/SK15602002A3/sk unknown
- 2001-04-25 DE DE50105249T patent/DE50105249D1/de not_active Expired - Lifetime
- 2001-04-25 KR KR1020027014691A patent/KR100779867B1/ko not_active IP Right Cessation
- 2001-04-25 DK DK01936275T patent/DK1280812T3/da active
- 2001-04-25 HU HU0300306A patent/HUP0300306A3/hu unknown
- 2001-04-25 AU AU6222901A patent/AU6222901A/xx active Pending
- 2001-04-25 NZ NZ522352A patent/NZ522352A/en unknown
- 2001-04-25 ES ES01936275T patent/ES2236234T3/es not_active Expired - Lifetime
- 2001-04-25 AT AT01936275T patent/ATE288442T1/de active
- 2001-04-25 IL IL15261201A patent/IL152612A0/xx unknown
- 2001-04-25 PL PL01358328A patent/PL358328A1/pl unknown
- 2001-04-25 RU RU2002132558/04A patent/RU2266911C2/ru not_active IP Right Cessation
- 2001-04-25 PT PT01936275T patent/PT1280812E/pt unknown
- 2001-04-25 CZ CZ20023547A patent/CZ20023547A3/cs unknown
- 2001-04-25 WO PCT/EP2001/004652 patent/WO2001083497A1/de active IP Right Grant
- 2001-04-25 EE EEP200200599A patent/EE05090B1/xx not_active IP Right Cessation
- 2001-04-25 AU AU2001262229A patent/AU2001262229B2/en not_active Ceased
- 2001-04-25 CN CN018088813A patent/CN1216890C/zh not_active Expired - Fee Related
- 2001-04-25 CA CA2407808A patent/CA2407808C/en not_active Expired - Fee Related
- 2001-04-25 JP JP2001580922A patent/JP5038572B2/ja not_active Expired - Fee Related
- 2001-04-25 BR BR0110459-4A patent/BR0110459A/pt not_active IP Right Cessation
- 2001-04-25 EP EP01936275A patent/EP1280812B1/de not_active Expired - Lifetime
- 2001-05-02 AR ARP010102068A patent/AR028398A1/es not_active Application Discontinuation
-
2002
- 2002-10-30 NO NO20025209A patent/NO330438B1/no not_active IP Right Cessation
- 2002-10-31 HR HRP20020864 patent/HRP20020864A2/xx not_active Application Discontinuation
- 2002-11-03 IL IL152612A patent/IL152612A/en not_active IP Right Cessation
- 2002-11-04 ZA ZA200208928A patent/ZA200208928B/en unknown
-
2003
- 2003-11-06 HK HK03108059A patent/HK1055745A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE316083T1 (de) | Adamantanderivate | |
MY136430A (en) | N-adamantylmethyl derivatives, pharmaceutical compositions containing them and processes for their preparation | |
AP1614A (en) | New heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-bacterial agents. | |
MXPA05013752A (es) | Procedimiento e intermediarios para la preparacion de (1r,2s,5s)-6,6-dimetil-3-azabiciclo[3,1,0]exan-2-carboxilatos o sales de los mismos. | |
NO20024772D0 (no) | Percyquinnin, fremgangsmåte for dets fremstilling og dets anvendelse som et legemiddel | |
AU2002319814A1 (en) | Substituted 1h-dihydropyrazoles, their preparation and use | |
GB0123589D0 (en) | Organic compounds | |
DE60112330D1 (en) | Pyrazolopyridinderivate | |
GB0109122D0 (en) | Novel compounds | |
DE69907419D1 (en) | Antitumorwirkstoffe | |
UA93529C2 (ru) | Соли и смеси 9-оксоакридин-10-уксусной кислоты c 1-алкиламино-1-дезоксиполиолами | |
MXPA02012889A (es) | Esteres de acidos 4-alcoxi-ciclohexano-1-amino-carboxilicos y procedimiento para su obtencion. | |
MXPA04005484A (es) | Procedimiento de preparacion de derivados de equinocandina. | |
HK1055745A1 (en) | Cyclipostins, a method for their production and the use of the same. | |
SE0102057D0 (sv) | New Salts I | |
WO2002100327A3 (en) | Substituted 1-benzazepines and derivatives thereof | |
AU2002248531A1 (en) | Pyrazolopyriadine derivatives | |
AU2002218422A1 (en) | New desloratadine salts, process for their synthesis and pharmaceutical compositions thereof | |
SE0102058D0 (sv) | New Salts II | |
AU2001244999A1 (en) | Naphthamide neurokinin antagonists for use as medicaments | |
GEP20032928B (en) | Halo Derivatives of 9-Deoxo-9a-Aza-9a-Homerythromycin A, Method for its Production, Pharmaceutical Compositions Containing the Same and Their Use for Treatment or Prevention of Bacterial Infections | |
MXPA03009723A (es) | Procedimientos e intermediarios para preparar epoxidos substituidos de bencilo. | |
DE60335960D1 (de) | 1,2,4-triazolderivat, verfahren zu dessenherstellung, und dieses enthaltende pharmazeutische zusammensetzung | |
MXPA04001856A (es) | Indan-1-oles c2-sustituidos y sus derivados, metodo para su produccion y su uso como medicamentos. | |
MXPA04001852A (es) | Uso de sistemas indan-1-ol c2-sustituidas para la produccion de medicamentos para la profilaxis o tratamiento de obesidad. |